GlobeNewsWire · ZYME · October 24, 2026

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

Get the app for more

Explore stock news, insights and company research.